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Abstract
 
The cytoplasmic protein tyrosine kinase Tec has been proposed to have important functions in
hematopoiesis and lymphocyte signal transduction. Here we show that Tec-deficient mice de-
veloped normally and had no major phenotypic alterations of the immune system. To reveal
potential compensatory roles of other Tec kinases such as Bruton’s tyrosine kinase (Btk), Tec/
 
Btk double-deficient mice were generated. These mice exhibited a block at the B220
 
1
 
CD43
 
1
 
stage of B cell development and displayed a severe reduction of peripheral B cell numbers, par-
ticularly immunoglobulin (Ig)M
 
lo
 
IgD
 
hi
 
 B cells. Although Tec/Btk
 
null
 
 mice were able to form
germinal centers, the response to T cell–dependent antigens was impaired. Thus, Tec and Btk
together have an important role both during B cell development and in the generation and/or
function of the peripheral B cell pool. The ability of Tec to compensate for Btk may also ex-
plain phenotypic differences in X-linked immunodeficiency (
 
xid
 
) mice compared with human
X-linked agammaglobulinemia (XLA) patients.
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Introduction
 
Nonreceptor protein tyrosine kinases (PTKs)
 
1
 
 are essential
for the development and activation of B and T lympho-
cytes. It has been shown that the stimulation of the anti-
gen-specific receptors (TCR on T cells, and B cell receptor
[BCR] on B lymphocytes) activates several members of
both the Src kinase (Lck, Fyn, Lyn) and Syk kinase (ZAP-
70 and Syk) family. Their critical involvement in signal
transduction pathways during these processes has been
demonstrated by a large number of studies and great detail
about their molecular functions and enzymatic activities is
known (1, 2).
Members of the Tec kinase family (Tec, Bruton’s ty-
rosine kinase [Btk], Itk, Rlk, and Bmx) form another class
of PTKs that are activated during lymphocyte development
and activation (3–5). Like Src kinases, Tec kinases have a
modular structure containing a short so-called Tec homol-
ogy (TH) domain, followed by src homology (SH) do-
mains SH3, SH2, and a kinase domain (SH1). However,
unlike Src kinases, they do not have an NH
 
2
 
-terminal
myristylation signal or a COOH-terminal negative regula-
tory tyrosine. Instead they contain an NH
 
2
 
-terminal Pleck-
strin homology (PH) domain (except Rlk). PH domains,
found in several intracellular signaling molecules, are able
to bind phosphatidylinositols and in some cases also medi-
ate protein–protein interactions (6). TH domains, contain-
ing proline-rich sequences, have been proposed to be in-
volved in the autoregulation of Tec kinases. It has been
shown that the TH and SH3 domains of Itk are able to in-
teract intramolecularly, thus preventing the interaction of
these domains with their prospective ligands (7).
The understanding of the physiological roles of the dif-
ferent members of the Tec kinase family is still at an early
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Abbreviations used in this paper:
 
 A-MuLV, Abelson murine leukemia vi-
rus; APC, allophycocyanin; BCR, B cell receptor; bio, biotin; BM, bone
marrow; Btk, Bruton’s tyrosine kinase; ECL, enhanced chemilumines-
 
cence; ES, embryonic stem; PH, Pleckstrin homology; PTK, protein
tyrosine kinase; SH, src homology; TD, thymus-dependent; TH, Tec
homology; TI-II, thymus-independent type II; 
 
xid
 
, X-linked immunode-
ficiency; XLA, X-linked agammaglobulinemia. 
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stage. Btk expressed in the B cell lineage and in myeloid
cells is the most extensively studied member of the Tec ki-
nase family. Mutations in Btk are the cause of X-linked
agammaglobulinemia (XLA) in humans (8). A mutation in
Btk has also been found in X-linked immunodeficiency
(
 
xid
 
) mice (9, 10) and targeted disruption of Btk in mice
confirmed that 
 
xid
 
 is caused by loss of Btk function (11,
12). The phenotype of 
 
xid
 
 or Btk knockout mice (
 
xid
 
/Btk)
resembles partially human XLA. The number of peripheral
B cells is about two- to threefold lower and the mature Ig-
M
 
lo
 
IgD
 
hi
 
 B cell population is severely reduced. 
 
xid
 
/Btk
mice lack peritoneal CD5
 
1
 
 B cells and have reduced serum
IgM and IgG3 levels. B cells isolated from these mice do
not proliferate in response to anti-IgM treatment and the
proliferation in response to LPS is reduced. In addition,
 
xid
 
/Btk mice are not able to mount a thymus-independent
type II (TI-II) response to antigens (11, 12). The effect of
Btk deficiency on B cell development remains controver-
sial. Some groups noticed either a small increase in the pro-B
cell fraction (B220
 
1
 
CD43
 
1
 
) of Btk-deficient and 
 
xid
 
 mice
(12) or a severe failure of Btk
 
null
 
 cells to expand to the small
pre-B cell stage in in vivo competition experiments (11). In
contrast, another group observed a developmental disad-
vantage of Btk
 
null 
 
B cells only past the pre-B cell stage (13).
It is likely that part of this controversial data may be ex-
plained both by the different experimental approaches and
by the different genetic background of the Btk-deficient
embryonic stem (ES) cells and blastocysts used in comple-
mentation or competition experiments.
The generation of Itk-deficient mice revealed that this
kinase has an important function during both T cell devel-
opment and activation (14, 15). Itk has also been suggested
to have a role in the CD28 costimulatory pathway, al-
though it remains to be determined whether Itk acts as a
positive or negative regulator of this signaling pathway (16–
18). Recently, evidence for an additional function for Itk
in the polarization of Th cells towards Th1 and Th2 has
been provided. Itk
 
null
 
 T cells were unable to polarize to-
wards a Th2 phenotype, even if primed under Th2-polar-
izing conditions (19).
Rlk/Txk is another member of the Tec kinase family
that, in contrast to other members, lacks the PH domain.
Rlk has been shown to be expressed in the T cell lineage,
preferentially in Th1 cells, and in mast cells and testis (20–
23). Deletion of Rlk by homologous recombination did
not reveal any major developmental alteration or signaling
defects within the T cell lineage (24). However, the gener-
ation of Itk/Rlk double-deficient mice and the analysis of
Itk/Rlk
 
null
 
 T cells have shown that Rlk is involved in
TCR-mediated signaling events, as indicated by an almost
completely absent proliferative response to anti-CD3 stim-
ulation. In addition, a further decrease in IL-2 and IFN-
 
g
 
production in Itk/Rlk double-deficient T cells compared
with Itk
 
null 
 
T cells was observed. Furthermore, double-defi-
cient mice showed an increased susceptibility to the intra-
cellular pathogen 
 
Toxoplasma gondii
 
 (24).
Tec, the founding member of the Tec kinase family, is
expressed in T and B cells, in myeloid cells, and in liver
 
(25–27). Recent in vitro studies have shown that Tec is ac-
tivated in response to BCR (27) or TCR/CD28 stimula-
tion (28). It has also been shown that CD28 engagement
leads to a recruitment of Tec (via its SH3 domain) to a pro-
line-rich motif within the cytoplasmic tail of CD28, and
overexpression of Tec activates both the IL-2 and IL-4
promoters (28, 29). Besides BCR- and TCR/CD28-medi-
ated signals, Tec is also activated by anti-CD19 (27) and
anti-CD38 (27) ligation, and by stimulation of the cytokine
receptors for IL-3 (30, 31), IL-6 (31), stem cell factor (32),
thrombopoietin (33), and GM-CSF (34).
The different studies on Tec function have not investi-
gated its role in primary T or B cells. To extend the analysis
of Tec function to an in vivo model, we generated Tec-
deficient mice by means of homologous recombination in
ES cells. Initial analysis of T and B lymphocytes, and of
other hematopoietic lineage cells, indicated no major phe-
notypic alterations. To reveal potential functions of Tec
that may be masked in lymphocytes by the expression of
the Tec kinase family member Btk, we intercrossed Tec-
deficient mice with Btk-deficient mice. Phenotypic analysis
of these mutant mice indicated that Tec and Btk have re-
dundant functions in B cell development and activation.
 
Materials and Methods
 
Generation of the Tec Targeting Construct.
 
A genomic clone
containing the region around Tec exon 2 was isolated from a 129
genomic library (Stratagene) and subcloned into pBluescript
(pBS; Stratagene). The short and the long arms of the targeting
construct were isolated as 4-kb BamHI-HindIII or 5.0-kb XhoI-
HindIII fragments, respectively. The fragments were cloned into
a pBS-based vector containing a polylinker with suitable cloning
sites and the thymidine kinase gene driven by the herpes simplex
virus enhancer/promoter elements (35). A pgk(G)neo(pA) cas-
sette was inserted between the short and the long arm of the tar-
geting construct. Therefore, proper targeting will result in the
deletion of a genomic fragment containing exon 2 (186 bp) and
surrounding intronic sequences. All cloning steps were performed
according to standard procedures (36). E14.1 ES cells (37)
 
 
 
were
transfected with 30 
 
m
 
g NotI-linearized targeting vector and cul-
tured on mitomycin C–treated murine embryonic fibroblasts. 2 d
after transfection, G418 (Geneticin; GIBCO BRL) was added to
a final concentration of 350 
 
m
 
g/ml and after another 2 d, gancy-
clovir (GANC) was added (2 
 
m
 
M final concentration) for nega-
tive selection. There was approximately threefold enrichment be-
tween plates with and without GANC. 9 d after transfection,
individual ES cell colonies were isolated, expanded, and subse-
quently Southern blot analysis was performed to detect homolo-
gous recombinants. Two targeted ES cell clones were injected
into E3.5 C57BL/6 blastocysts and transferred into (B6/D2) F1
pseudopregnant females. Chimeric mice obtained were then
backcrossed to C57BL/6 mice and transmission of the targeted
allele was confirmed by Southern blot analyses of tail DNA.
 
Btk-deficient Mice.
 
Btk-deficient mice (12) were purchased
from The Jackson Laboratory.
 
Generation of A-MuLV–transformed Cell Lines.
 
Pre-B cell lines
were Abelson murine leukemia virus (A-MuLV)–transformed as
described (38). 2 
 
3
 
 10
 
6
 
 bone marrow (BM) cells from the various
knockout mice were infected with A-MuLV in RPMI (supple-
mented with 20% FCS, 50 
 
m
 
M 
 
b
 
-mercaptoethanol, 2 mM 
 
L
 
-glu- 
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tamine, and 50 U/ml penicillin/streptomycin) in the presence of
10 
 
m
 
g/ml polybrene, and incubated for 10 d. Transformed pre-B
cells were then split into new wells and grown in RPMI (supple-
mented with 10% FCS, 50 
 
m
 
M 
 
b
 
-mercaptoethanol, 2 mM 
 
L
 
-glu-
tamine, and 50 U/ml penicillin/streptomycin).
 
Immunoprecipitation and Western Blotting.
 
For immunoprecipi-
tation and Western blotting experiments, splenocytes from one
spleen or 50 
 
3
 
 10
 
6
 
 pre-B cells were lysed in NP-40 lysis buffer
(1% NP-40, 150 mM NaCl, and 50 mM Tris-HCl) supple-
mented with protease inhibitors (Complete; Roche). The lysates
were cleared from nuclei and debris and the Ab used for immu-
noprecipitation was added (rabbit anti–C-term Tec [39]). After
incubating for 3 h at 4
 
8
 
C, the immune complexes were precipi-
tated by addition of 30 
 
m
 
l protein A (50% slurry, prewashed in
lysis buffer) followed by an additional incubation for 1 h at 4
 
8
 
C.
After several washes with lysis buffer, the Ab–protein A com-
plexes were loaded on a 9% polyacrylamide-SDS gel. 100 
 
m
 
g of
protein was used when Western blotting experiments were per-
formed with total cell lysates. Proteins were transferred onto a
polyvinylidene difluoride (PVDF) nylon membrane (Roche),
blocked, and incubated with an Ab suitable for Western blotting
(rabbit anti–SH3-Tec [30]) in PBS-Tween (supplemented with
5% nonfat dry milk). After the incubation with the secondary Ab
(protein A–horseradish peroxidase; Zymed Laboratories), the sig-
nals were detected with the enhanced chemoluminescence (ECL)
system (Pierce Chemical Co.).
 
B Cell Proliferation Assays.
 
To obtain enriched B cell popula-
tions, splenocytes were stained with a PE-conjugated Ab mix
containing anti-CD43 (clone S7), anti–Gr-1 (RB6-8C5), and
anti-CD11b (M1/70). The cells were washed and stained with
anti-PE magnetic beads and loaded onto a negative enrichment
column (Miltenyi Biotec). The purity of the B cell population was
 
z
 
50–80% for the Tec/Btk double knockout and 
 
.
 
85% for the
other genotypes. The purified cells (i.e., an equivalent of 5 
 
3
 
 10
 
4
 
B220
 
1
 
 B cells) were then incubated with the appropriate stimuli
in 160 
 
m
 
l proliferation medium (RPMI supplemented with 10%
FCS, 50 
 
m
 
M 
 
b
 
-mercaptoethanol, 2 mM 
 
L
 
-glutamine, and 50 U/ml
penicillin/streptomycin). Anti-IgM (F[ab
 
9
 
]
 
2
 
 fragment) and LPS
were used at concentrations of 0.3, 1, and 5 
 
m
 
g/ml.
 
ELISA Assay.
 
Isotype-specific Ab titers were detected ac-
cording to standard ELISA protocols. In brief, ELISA plates (Dy-
nax) were coated overnight with 2 
 
m
 
g/ml isotype-specific goat
anti–mouse Abs (Southern Biotechnology Associates, Inc.). Di-
luted serum samples (isolated from 7–10-wk-old mice) were
added. After overnight incubation, the bound isotype-specific
Abs were detected with an alkaline phosphatase–conjugated goat
anti–mouse Ig (H plus L) Ab (Southern Biotechnology Associ-
ates, Inc.). Alkaline phosphatase activity was determined with
 
p
 
-nitrophenyl phosphate (pNPP) tablets as a substrate (Sigma-
Aldrich). Abs used as standards were purchased from either BD
PharMingen or Southern Biotechnology Associates, Inc.
 
TI-II Antigen Immunization.
 
10 
 
m
 
g TNP-Ficoll (in PBS) was
intraperitoneally injected. TNP-specific Ab titers were deter-
mined 5 d later by ELISA. ELISA plates were coated overnight
with 1 
 
m
 
g/ml TNP-BSA. Several dilutions of both preimmuni-
zation and postimmunization serum were added. Isotype-specific
Abs were detected with an alkaline phosphatase–conjugated goat
anti–mouse Ig (H plus L) Ab (Southern Biotechnology Associ-
ates, Inc.). Alkaline phosphatase activity was determined with
pNPP tablets as a substrate (Sigma-Aldrich).
 
Thymus-dependent Antigen Immunization.
 
20 
 
m
 
g TNP-KLH
was allowed to adsorb on 2 mg of aluminum hydroxide for 1 h at
4
 
8
 
C. Nonadsorbed TNP-KLH was washed away with PBS, and
 
the TNP-KLH/aluminum hydroxide mixture was resuspended
in 200 
 
m
 
l PBS and intraperitoneally injected. KLH-specific serum
titers were determined 13 d later by ELISA. For secondary im-
mune responses, mice were injected 8 wk after the primary im-
munization with TNP-KLH/aluminum hydroxide (20 
 
m
 
g in 200
 
m
 
l PBS) and KLH-specific serum titers were determined 7 d after
the secondary injection by ELISA. ELISA plates were coated
overnight with 1 
 
m
 
g/ml KLH-BSA and several dilutions of the
preimmunization and postimmunization serum were added.
Isotype-specific Abs were detected with an alkaline phosphatase–
conjugated goat anti–mouse Ig (H plus L) Ab (Southern Biotech-
nology Associates, Inc.). Alkaline phosphatase activity was deter-
mined with pNPP tablets as a substrate (Sigma-Aldrich).
 
Immunohistochemistry.
 
Spleens were frozen in Tissue-Tek
(Sakura Finetek). Sections (8–12 
 
m
 
m) were stained overnight
with the appropriate Abs. Afterwards, the sections were washed
and subsequently incubated with the secondary Abs for 3 h at
room temperature. For germinal center detection, mice were im-
munized with TNP-KLH/aluminum hydroxide and spleens
were isolated 11 d after immunizations. The reagents used for
immunohistochemistry were FITC-conjugated anti-B220 (clone
RA3-6B2; Caltag), biotin (bio)-conjugated anti-TCR
 
b
 
 (H57-
597; BD PharMingen), rat IgM anti–murine MOMA-1 (40),
Cy3-strepatvidin and Cy5-streptavidin (Cedarlane), Cy3-goat
anti–rat IgM and Cy3-goat anti–rat IgG (Jackson ImmunoRe-
search Laboratories), and bio–peanut agglutinin (PNA; Vector
Laboratories). Visual data were acquired with an Axioplan 2 fluo-
rescent microscope (ZEISS).
 
Flow Cytometric Analysis and Abs.
 
Thymus, lymph nodes, and
spleen were removed from killed animals (5–12 wk of age) and
placed into 60-mm tissue culture dishes containing staining buffer
(PBS supplemented with 2% FCS and 0.1% sodium azide). Single
cell suspensions were made by passing the tissue through a 70-
 
m
 
m nylon cell strainer. BM was isolated from both femurs and
pooled. The cell suspensions were washed once with staining
buffer and 1–5 
 
3
 
 10
 
5
 
 cells were incubated on ice with Fc block
(BD PharMingen) for 5 min and subsequently with the appropri-
ate Abs for 30 min. Afterwards, the cells were washed once with
staining buffer and analyzed or incubated with secondary Abs on
ice for 30 min. The following Abs were used for FACS
 
®
 
 staining.
From Caltag: FITC–, PE–, or bio–anti-B220 (RA3-6B2), PE–
or bio–anti-mCD3 (clone 500-A2), PE–anti-mCD8
 
a
 
 (CT-
CD8
 
a
 
), Tricolor–anti-mCD4 (CT-CD4), and Tricolor-strepta-
vidin; from BD PharMingen: allophycocyanin (APC)–anti-B220
(clone RA3-6B2), PE–anti-CD43 (S7), FITC– or bio–anti-IgM
(II/41), FITC–anti-IgD (11-26c.2a), FITC–anti-CD3
 
e
 
 (145-
2C11), PE–anti-CD5 (53-7.3), bio–anti-V
 
a
 
11 (RR8-1), bio–
anti-V
 
b
 
8.1/8.2 (MR5-2), PE–anti-Gr-1 (RB6-8C5), PE–anti-
CD11b (M1/70), PE–anti-CD11c (HL-3), APC–anti-mCD4
(RM4-5), FITC– or bio–anti-HSA (M1/69), bio–anti-CD69
(H1.2F3), bio–anti-mTCR-
 
g
 
/
 
d
 
 (GL3), and bio–anti–mTCR-
 
a
 
/
 
b
 
(H57-597). Cells were analyzed using a FACScan™ flow cyto-
meter and CELLQuest™ software (Becton Dickinson).
 
Results
Generation of Tec-deficient Mice by Homologous Recombination
The murine Tec gene contains 18 exons spanning .86
kb (41). Two major splice variants have been described:
Tec IV, encoding the full-length protein, and Tec III, con-
taining a 66-bp deletion within exon 8. Minor splice1614 Tec and Btk Are Required for Murine B Cell Development
forms, Tec I and II, are generated by usage of alternative
exons 18a and 4a instead of exons 18 and 4, respectively
(26, 41). Specific roles of the different isoforms are not
known, and it remains unclear whether all of the potential
protein isoforms indeed exist in vivo. To ensure the inacti-
vation of all the possible splice forms, we deleted exon 2,
which harbors the translation initiation codon and 45 addi-
tional amino acids of the PH domain. A similar targeting
strategy has been used successfully for the generation of
Btk-deficient mice (12). Therefore, a HindIII-XhoI frag-
ment containing exon 2 plus 59 and 39 intronic sequences
was replaced with pgk(G)neo(pA). The deletion of the first
46 amino acids should result in the complete inactivation of
Tec protein synthesis. However, as two potential transla-
tion initiation codons are located either at the beginning of
the TH (exon 5) or SH3 (starting at exon 7) domain, it re-
mained possible that truncated forms of Tec (of a size of 60
and 52 kd, respectively) would be generated (Fig. 1 A). To
confirm that the targeting strategy resulted in abrogation of
Tec expression (and to determine whether potential trun-
cated forms of Tec were generated), a series of immuno-
blotting experiments was performed on A-MuLV–trans-
formed pre-B cells generated from mutant and wild-type
littermate control mice. Immunoprecipitation of Tec from
lysates with a rabbit anti–mouse COOH-terminal Tec Ab
followed by Western blotting with a rabbit anti–mouse
Tec-SH3 domain Ab confirmed the absence of the full-
length 73-kd Tec protein (Fig. 1 D). Direct Western blot-
ting of A-MuLV–transformed pre-B cells and of total sple-
nocyte lysates with the anti–Tec-SH3 Ab detected no
truncated forms of Tec, indicating that the deletion of exon
2 resulted in the inactivation of the gene (Fig. 1 E).
Phenotypic Analysis of Tec-deficient Mice
Tec-deficient mice were viable and fertile, and did not
show any gross developmental defects. Even though it has
Figure 1. Deletion of the Tec
gene by homologous recombination
in ES cells. (A) Schematic map of
Tec kinase indicating the PH do-
main, the TH domain, and the SH
domains SH3, SH2, and SH1 (kinase
domain). The vertical arrows with
an asterisk indicate potential transla-
tion initiation sites downstream of
the first ATG within the Tec coding
region. The hatched area within the
PH domain indicates the region of
the Tec kinase deleted by the applied
targeting strategy. (B) Schematic
map of the targeting construct (top),
and of the Tec locus before and after
homologous recombination (middle
and bottom, respectively). Only re-
striction sites important for the tar-
geting strategy are shown. The hori-
zontal thick black line (in the top
and bottom) indicates the region of
homology between the targeting
construct and the endogenous locus.
The bar with an asterisk in the mid-
dle part represents the probe used for
Southern blotting to detect homolo-
gous recombination. Thick-lined
rectangles in the middle and lower
part represent exons. Exon 1 con-
tains the 59 untranslated region, and
exon 2 (186 bp) contains the first 46
amino acids including the initiation
codon (reference 41). The length of
introns 1 and 2 are .30 kb and z23
kb, respectively (reference 41). Hor-
izontal bars with numbers (indicating
the size in kb) represent the expected
genomic fragments after digestion
with BamHI. X, XhoI; H, HindIII.
(C) Southern blot of BamHI di-
gested tail DNAs showing wild-type (1/1), heterozygous (1/2), and homozygous (2/2) knockout mice. The origin of the detected wild-type (WT)
and targeted (targ.) fragments is indicated in B. (D) Immunoprecipitation (IP) and Western blot (WB) analysis of Tec kinase from A-MuLV–transformed
pre-B cell lines. Tec kinase was immunoprecipitated from NP-40 lysates with a rabbit Ab against the COOH-terminal region of Tec. Tec kinase was de-
tected with a rabbit Ab against the SH3 domain of Tec followed by ECL. The strong signal around 50 kd is due to the rabbit heavy chain (hc) of the rab-
bit Ab used for the immunoprecipitation. (E) Western blot (WB) analysis of Tec kinase from NP-40 lysates of splenocytes or A-MuLV–transformed pro-B
cell lines. Tec kinase was detected with a rabbit Ab against the SH3 domain of Tec followed by ECL.1615 Ellmeier et al.
been shown that Tec is expressed within the T and B cell
lineage and in cells of myeloid origin, no developmental al-
terations were observed within these cell populations. The
number of splenic T and B cells in Tec2/2 mice was similar
to that in wild-type littermate controls (Fig. 2, A and B).
The IgM versus IgD expression pattern on peripheral B
cells (Fig. 2 C) and the developmental profile of B cells in
the BM (Fig. 3) were indistinguishable between wild-type
and Tec-deficient mice. Peritoneal CD51 B cells were
present in the knockout mice (not shown). In addition, T
cell development appeared to be normal in Tec-deficient
mice and FACS® analysis of BM cells or splenocytes for the
expression of the surface molecules TER119, CD61, Gr-1,
CD11b, and NK1.1 did not reveal any differences in Tec-
null mice compared with wild-type mice (data not shown).
Thus, Tec kinase is not essential for the development of
cells in the hematopoietic system.
To reveal potential nonredundant functions of Tec dur-
ing T cell signaling, both in vitro and in vivo experiments
were performed. Purified T cells from Tec-deficient mice
proliferated like their wild-type counterparts in response to
anti-CD3 stimulation and showed similar induction of
CD25 and CD69 (data not shown). As Tec has been impli-
cated in the signaling pathways mediated by CD28 costim-
ulation (28), the effect of anti-CD28 Ab treatment upon
suboptimal anti-CD3 stimulation was also determined.
Tec-deficient T cells responded to CD28 stimulation like
wild-type T cells, with respect to both proliferation and
IL-2 production (data not shown). In agreement with the
in vitro results, the ex vivo responses to KLH of Tecnull or
Figure 2. Reduced B cell numbers and
altered IgM/IgD profile in the periphery of
Tec/Btk double-deficient mice. (A) Flow
cytometric analysis of spleen (top) and
lymph nodes (bottom) isolated from the
mice of the indicated genotype. The lym-
phocytes were stained with anti-B220 and
anti-CD3 Abs. Numbers next to the gates
in the dot plots indicate percentage of gated
cells. (B) The numbers of B2201 and CD31
lymphocytes in the spleen. Open circles
represent individual mice (5–11 spleens per
genotype were counted). Thick solid bars
indicate average numbers for B cells (34.4 6
17.3, 29.5 6 14.4, 11.9 ± 8.2, and 4.5 6
4.0 million for wild-type, Tec-deficient,
Btk-deficient, and Tec/Btk double knock-
out mice, respectively). (C) IgM versus IgD
FACS® profile of B220-gated lymphocytes
from spleen (top) and lymph nodes (bot-
tom) isolated from mice of the indicated
genotype. The numbers in the dot plots
show the percentage of cells within each
quadrant. (A, B, and C) Wild-type (WT),
Tec-deficient (Tec), Btk-deficient (Btk),
and Tec/Btk double-deficient (Tec/Btk)
mice were littermates. (A and C) 50,000
splenocytes were collected for FACS® anal-
ysis.1616 Tec and Btk Are Required for Murine B Cell Development
wild-type T cells isolated from the draining lymph nodes of
KLH-immunized mice were indistinguishable (data not
shown).
To identify a potential role for Tec in signaling pathways
induced by BCR stimulation or by polyclonal B cell activa-
tors, purified B cells from Tec2/2 and littermate control
mice were stimulated either with anti-IgM Ab or with LPS.
As shown in Fig. 4, B cells from both sets of mice showed
similar proliferative responses. In addition, Tec-deficient B
lymphocytes responded like wild-type B cells to anti-CD40
or anti-CD40 plus IL-4 stimulation, and anti-IgM cross-
linking induced a similar calcium flux in Tecnull B cells com-
pared with their wild-type counterparts (data not shown).
Phenotypic Analysis of Mice Deficient in Both Tec and Btk
B Cell Development. Because the initial phenotypic
characterization of Tec2/2 mice did not reveal any major
developmental or signaling defect within B and T cell lin-
eages, we decided to test whether other Tec kinases com-
pensate for Tec in Tec-deficient mice. To reveal compensa-
tory pathways for the B cell lineage, Tec knockout mice
were crossed to Btk-deficient mice (12).
Btk knockout and xid mice display an approximately
two- to threefold reduction of splenic B cells and the re-
maining B2201 cells are reduced in numbers that express
the mature IgMloIgDhi surface phenotype. Peritoneal
CD51 B cells are missing and the mice have low IgM and
IgG3 serum levels (11, 12). FACS® analysis of cells from
spleen and lymph nodes of Tec/Btk double-deficient mice
revealed a dramatic reduction of B cells compared with Btk
single knockout mice (Fig. 2, A and B). A similar reduction
in B2201 cells was also observed in peripheral blood lym-
phocytes (data not shown). Analyses of the maturational
status of the Tec/Btk double-deficient B cells revealed a
further relative decrease of the mature IgMloIgDhi popula-
tion (Fig. 2 C).
To investigate whether the deletion of both Tec and Btk
also affects B cell development, BM cells from the various
mutant mice were isolated and analyzed for the expression
of B220, CD43, and IgM. Pro-B cells (or fractions A–C;
nomenclature according to references 42 and 43, respec-
tively) express CD43, whereas pre-B cells (fractions D–F)
lose its expression. As shown in Fig. 3 A, the majority of
wild-type or Tec-deficient B2201 BM cells did not express
CD43. A small increase in B2201CD431 B lymphocytes
was observed in Btknull mice, as described previously (12,
13). In contrast, Tec/Btk double-deficient mice displayed
an accumulation of CD431 B cell precursors, indicating a
partial developmental block at the large pre-B cell stage. At
this stage, developing B cells become dependent on pre-
Figure 3. Partial block in B cell develop-
ment in Tec/Btk double-deficient mice.
(A) BM cells of the indicated genotype were
analyzed for the expression of B220 and
CD43 by FACS® analysis. The numbers in
the dot plots show the percentage of cells
within each quadrant. (B) B220 versus IgM
profile of BM cells isolated from mice of the
indicated genotype. The numbers in the dot
plots show the percentage of cells within
each quadrant. (A and B) Wild-type (WT),
Tec-deficient (Tec), Btk-deficient (Btk),
and Tec/Btk double-deficient (Tec/Btk)
mice were littermates. The numbers in the
dot plots show the percentage of cells
within each quadrant.
Figure 4. Proliferative response of B cells to anti-IgM and LPS stimula-
tion. Purified splenic B cells isolated from mice of the indicated genotypes
were stimulated with the indicated amounts of anti-IgM (left) or LPS
(right). Cell proliferation was measured by [3H]thymidine incorporation.
Experiments were done in triplicates and standard deviations are indicated
with error bars. WT, wild-type; Tec, Tec-deficient; Btk, Btk-deficient;
Tec/Btk, Tec/Btk double-deficient.1617 Ellmeier et al.
BCR–mediated signaling for their further maturation into
surface IgM-expressing immature B cells (44). However,
some surface IgM1 immature B cells did develop in Tec/
Btk double-deficient mice (Fig. 3 B).
B Cell Proliferation. The ability of purified splenic B
cells from the different mutant strains to respond to exter-
nal signals was determined by culturing them in the pres-
ence of anti-IgM or LPS. Neither Btknull (as described
previously [12]) nor Tec/Btk double-deficient B cells pro-
liferated in response to anti-IgM treatment (Fig. 4, left) and
the response to LPS was further reduced in Tec/Btknull
compared with Btknull B cells (Fig. 4, right). The response
to anti-CD40 treatment was slightly reduced in Tec/Btk
double-deficient B cells compared with Btk-deficient cells,
although addition of IL-4 to anti-CD40 treated B cells re-
sulted in similar levels of proliferation independent of the B
cell genotype (data not shown).
Serum Ig Levels and Antigen-specific Responses
To investigate whether the decrease in peripheral B cell
numbers correlates with a reduction of serum Ig levels,
ELISAs were performed. As shown in Fig. 5, serum Ig lev-
els in Tec/Btk mice were similar to those in Btk knockout
mice, reflected by a decrease in the amount of IgM, IgG3,
and IgG2a subtypes. In addition, IgG1 and IgA levels were
slightly lower in the double knockout mice compared with
the other mice. This indicates that still significant numbers
of Ig-producing plasma cells were induced in Tec/Btk
double-deficient mice.
To test the ability of Tec/Btk double knockout mice to
mount an antigen-specific immune reaction, we deter-
mined the response to both TI-II and thymus-dependent
(TD) antigens. For TI-II responses, four mice of each geno-
type were intraperitoneally injected with TNP-Ficoll and
5 d later TNP-specific IgM and IgG3 Abs levels were de-
tected by ELISA. Btk-deficient mice, in agreement with
previous findings (11, 12), lacked TI-II responses, as did
Tec/Btk knockout mice. Tec-deficient mice responded
like wild-type mice to TI-II antigens (Fig. 6 A).
The primary response to TD antigens was measured 13 d
after intraperitoneal injection of TNP-KLH adsorbed on
aluminum hydroxide. As shown in Fig. 6 B, equal TNP-
specific IgM and IgG1 responses were observed in wild-
type and Tec-deficient mice. In agreement with previous
studies (12), the TNP-specific IgM and IgG1 response was
reduced in Btk-deficient mice compared with wild-type
mice. Tec/Btk double knockout mice showed a further
reduction in the primary TNP-IgG1 response despite a
TNP-specific IgM response similar to that of Btknull mice.
To examine the secondary immune response, mice were
boosted 6 wk after the primary immunizations by injection
of TNP-KLH/aluminum hydroxide and the TNP-specific
Ig isotype titers were determined 7 d later. As shown in
Fig. 6 C, Tec/Btk-deficient mice had a lower secondary
IgG1 response than Btknull mice. Strikingly, the IgG2a re-
sponse was barely detectable in Tec/Btknull mice. This indi-
cates an important role for Tec and Btk in the generation
of an antigen-specific immune response.
Figure 5. Similar levels of se-
rum Ig in Btk- and Tec/Btk-
deficient mice. Serum Ig levels
of 7–10-wk-old mice of the in-
dicated genotype were deter-
mined by ELISA. WT, wild-
type; Tec, Tec-deficient; Btk,
Btk-deficient; Tec/Btk, Tec/Btk
double-deficient..1618 Tec and Btk Are Required for Murine B Cell Development
Disrupted Splenic Architecture in Tec/Btk Double-deficient
Mice. To investigate whether the reduced number and
the immature phenotype of peripheral B cells in Tec/Btk-
deficient mice also affected the general architecture of the
spleen, cryosections were stained with anti-B220, anti-
TCR, and anti–MOMA-1 Abs to reveal the localization of
B cells, T cells, and metallophilic marginal zone macro-
phages, respectively. The morphology of the white pulp
appeared normal in Tec-deficient mice. B and T cell areas
surrounded by a well-defined marginal zone could be iden-
tified (Fig. 7 B). In Btk-deficient mice, large B and T cells
areas were also clearly detected, although we observed a
discontinuity of the MOMA-11 marginal zone macro-
phage layer (Fig. 7 C). In contrast, the structure of the
white pulp in Tec/Btk double-deficient mice was altered
(Fig. 7 D). Only few clearly defined but small follicular
structures were observed. The majority of the B2201 B cell
areas appeared to be loosely associated with T cell areas and
no clear and distinct surrounding anti–MOMA-1 staining was
observed, indicating an increased discontinuity of the mar-
ginal zone compared with Btknull mice. Marginal zone B
cells were present, however, as revealed by anti-CD21 and
anti-CD23 FACS® staining (data not shown). Germinal
centers, identified by PNA staining after primary immuni-
zation with TNP-KLH, were clearly observed in wild-type
and Tec-deficient mice (Fig. 7, E and F, respectively). In
agreement with other studies (45), we also could detect
GCs in Btknull mice (Fig. 7 G), although their frequency
appeared to be reduced compared with wild-type and Tec-
deficient mice. Germinal centers were also detected in
Tec/Btk double-deficient mice (Fig. 7 H). Their frequency
was further reduced compared with Btknull mice, most
likely due to the lower numbers of B cells in Tec/Btk-defi-
cient mice.
Figure 6. In vivo response to TI-II and TD antigens. (A) Response to TI-II antigen: four mice of the indicated genotype were immunized with TNP-
Ficoll and the TNP-specific IgM and IgG3 isotype levels are shown in the left and right panel, respectively. A representative mouse is shown for each
genotype. Dotted lines with open squares indicate levels in the preimmune serum. Serum dilution steps were threefold starting from 1:100. (B) Primary
immune response to TD antigen: six mice of the indicated genotype were immunized with TNP-KLH and TNP-specific IgM and IgG1 are shown in
the left and right panel, respectively. Dotted lines with open squares indicate levels in the preimmune serum. Serum dilution steps were threefold starting
from 1:100 for IgM and 1:30 for IgG1. (C) Secondary immune response to TD antigens: 8 wk after the primary immunization, mice were reimmunized
with TNP-KLH and TNP-specific IgM, IgG1, and IgG2a are shown in the left, middle, and right panel, respectively. Dotted lines with open squares in-
dicate serum levels before the second TNP-KLH injection. Serum dilution steps were threefold starting from 1:100 for IgM and IgG2a and 1:900 for
IgG1. (B and C) The average serum isotype titers of six mice are shown for each dilution. Standard deviations were omitted from the graphs, because of
variation in the absolute levels of Ig isotypes among individual mice within each genotype group. However, the shape of the dilution curves is similar for
each mouse within each genotype group. (A, B, and C) Wild-type (WT), Tec-deficient (Tec), Btk-deficient (Btk), and Tec/Btk double-deficient (Tec/
Btk) mice were age-matched controls.1619 Ellmeier et al.
Discussion
Members of the Tec kinase family are nonreceptor PTKs
that are activated during lymphocyte development and ac-
tivation (3–5). Tec is expressed in cells of the myeloid lin-
eage, in T and B cells, and in liver (25–27). In this study,
we generated Tec-deficient mice to gain insight into the
biological role of Tec. Mice homozygous for the disruption
of Tec were viable and fertile, and FACS® analysis of Tec2/2
mice did not reveal any developmental defects within the
hematopoietic lineage. In addition, Tec-deficient B and T
lymphocytes behaved like wild-type cells in both in vitro
proliferation assays and in vivo immunization experiments.
To investigate whether Btk compensated for the loss of
Tec in B cells, Tec-deficient mice were intercrossed with
Btk knockout mice (12). Tec/Btk double-deficient mice
displayed a severe reduction of peripheral B cell numbers,
most likely caused by a partial block of B cell development
at the B2201CD431 to B2201CD432 transition. Further-
more, the percentage of mature IgMloIgDhi B cells within
the peripheral B cell pool was further reduced in the dou-
ble knockouts compared with the Btk single knockout and
secondary TD immune responses were almost absent. Our
study thus reveals a differential dependency of peripheral
and developing murine B cells for the function of members
of the Tec family. During B cell development, Tec and Btk
share common functions and thus the activity of either Tec
or Btk is required for the proper generation of immature B
cells. Btk function appears to be more important than that
of Tec, as a moderate reduction of pre-B cells was observed
in Btk-deficient mice, but not in those lacking Tec. In the
periphery, Btk appears to have additional unique functions
that are only partially shared by Tec.
Tec Is Not Essential for B and T Cell Development and Func-
tion. Studies have shown that Tec is expressed in several
human B cell lines that represent various stages of B cell
development (27). Cross-linking of the BCR with anti-
IgM Abs induces tyrosine phosphorylation of Tec in ma-
ture B cell lines and also causes an increase in the tyrosine
kinase activity of Tec. Similarly, in immature B cell lines,
Tec becomes tyrosine phosphorylated upon stimulation via
various cell surface molecules. In T cells it has been dem-
onstrated that Tec becomes activated upon anti-CD3 or
anti-CD28 stimulation and that Tec physically interacts
with CD28 in an activation-dependent manner (28). Fur-
thermore, overexpression of a wild-type or kinase-dead
form of Tec enhanced or suppressed IL-2 expression, re-
spectively (28). Taken together, these studies suggested that
Tec might have important functions both during B cell de-
velopment and in signaling pathways in mature lympho-
cytes. However, analysis of Tec-deficient mice did not re-
veal any defect within the B and T cell lineage. All major B
cell populations, both in the BM and in the periphery,
were present and the total numbers of splenic B and T cells
Figure 7. Disrupted splenic architecture in Tec/Btk double-deficient mice. (A–D) Cryosections of spleens of the indicated genotype were stained with
anti-B220 (green), anti-TCRb (blue), and anti–MOMA-1 (red). Original magnifications: 350. M, Moma-11 marginal zone macrophage layer; T, T cell
area. (E–H) Cryosections of spleens from mice immunized with TNP-KLH. B cell follicles (B) are shown in green (anti-B220) and PNA1 areas (in red)
within the B cell follicles indicate germinal centers (gc). Original magnifications: 3200. 1620 Tec and Btk Are Required for Murine B Cell Development
were similar to wild-type control mice. In addition, CD51
peritoneal B cells were present in the Tec knockout mice.
Tec has also been implicated to function in myeloid cells
(30, 46). Although the experiments described in this study
did not address whether Tec2/2 myeloid cells are still func-
tional, FACS® analysis of Tec-deficient mice did not show
any developmental alterations within the myeloid lineages.
To identify potential signaling defects in B or T cells,
both in vitro and in vivo experiments were performed.
Neither anti-IgM, LPS, or anti-CD40 treatment of B cells
nor anti-CD3 or anti-CD3 plus anti-CD28 treatment of T
cells revealed any proliferative defect due to the absence of
Tec. Anti-IgM cross-linking induced a calcium flux in
Tec-deficient B cells that was similar to that in wild-type
counterparts. Anti-CD3 plus anti-CD28 stimulation also
induced similar levels of IL-2 in Tec2/2 T cells compared
with wild-type T cells. In vivo, TI-II and TD immune re-
sponses were normal as were the ex vivo T cell responses to
KLH. Further experiments such as exposing Tec2/2 mice
to different pathogens are required to finally determine
whether Tec-deficient mice indeed have normal immune
responses.
Several Tec kinase family members are expressed within
the B and/or T cell lineage. For example, B cells express
Btk and Tec and low levels of Bmx, and T cells express Itk,
Tec, and Rlk. The absence of any developmental and/or
signaling defect in Tec-deficient mice could thus be ex-
plained by the fact that other Tec family kinases are able to
compensate for the loss of Tec. Indeed, in Btk-deficient
human XLA B cells or in chicken DT-40 cells, the defect
in phospholipase Cg2 phosphorylation and Ca21 mobiliza-
tion can be overcome by overexpression of any Tec kinase
family member (47, 48). The ability of these kinases to at
least partially replace each other has also been shown for
murine T cells. Itk/Rlk double-deficient mice have a more
severe phenotype than Itk single-deficient mice, indicating
that Rlk partially compensates for the loss of Itk (24). In
contrast, Itk and perhaps other members of the Tec kinase
family are able to fully compensate for the loss of Rlk, as
those mice have no major developmental or signaling de-
fect within the T cell lineage (24).
Tec and Btk Are Essential for B Cell Function and Develop-
ment. To test whether Btk is able to compensate for the
loss of Tec in the B cell lineage and therefore masks path-
ways using Tec kinase, we intercrossed Tec-deficient mice
with Btk knockout mice (12). FACS® analysis of PBLs and
secondary lymphoid organs of Tec/Btk double-deficient
mice showed that both Tec and Btk are required for the
proper maturation of peripheral B cells. Not only was the
percentage of mature IgMloIgDhi cells within the peripheral
B cell pool further decreased compared with Btknull cells,
but Tec/Btk-null mice also had severely reduced numbers
of peripheral B cells. The absolute numbers of B2201 sple-
nocytes were three- to fourfold reduced in Tec/Btk-defi-
cient compared with Btknull mice. In addition to the defect
in the peripheral B cell compartment, Tec/Btk-deficient
mice exhibited a defect during B cell development. There
was an accumulation of B2201CD431 pro- and pro/pre-B
cells, at the stage at which developing B cells become de-
pendent on pre-BCR signals for their further maturation
into surface IgM–expressing immature B cells (44). The ac-
tivity of either Tec or Btk is thus required to allow pro-
gression through this crucial developmental stage. In the
absence of both Tec and Btk, only a few cells are able to
develop into immature B cells. This indicates an essential
role for Tec family kinases during pre-BCR signaling in
the murine system.
The partial block during B cell development could ex-
plain the dramatic drop in peripheral B cell numbers in
mice lacking both Tec and Btk. Therefore, one may expect
to observe in these mice a slow accumulation of peripheral
B cells that could develop in the absence of both Tec and
Btk with increasing age. However, as older mice (4–5 mo)
still showed low numbers of peripheral B cells (Ellmeier,
W., and D.R. Littman, unpublished data), it remains possi-
ble that the absence of both Tec and Btk causes additional
defects within the B cell lineage. Peripheral B cells could
have a decreased life span due to defects in BCR signaling
(49). In addition, the selection of immature B cells in the
BM and/or the emigration out of the BM could be im-
paired (50).
Despite the reduced number of peripheral B cells in
Tec/Btk double-deficient mice, their serum Ab titers were
similar to those in Btk knockout mice at 8–12 wk of age. It
has been shown that Btk is essential for an immune re-
sponse to TI-II antigens. Thus, it was not surprising that
Tec/Btk-deficient mice also failed to respond to TNP-
Ficoll. Btknull mice, however, are able to respond to TD
antigens such as TNP-KLH. Both Btk- and Tec/Btk-defi-
cient mice mounted similar IgM responses, but the primary
IgG1 response was dramatically reduced in Tec/Btk-deficient
mice. The secondary IgG1 and IgG2a immune responses
were low in Btknull mice but were virtually absent in Tec/
Btk-deficient mice. Thus, the formation and/or activation
of memory B cells are strongly dependent on signals trans-
mitted by either Tec or Btk, and these processes are im-
paired despite formation of germinal centers (although of
small size) in Tec/Btk-deficient mice. The requirement for
both Tec and Btk in B cell signaling pathways is also indi-
cated by the reduced proliferative response to LPS stimula-
tion in the double-deficient B cells compared with Btk-
deficient B lymphocytes. However, as the B cell areas and
the marginal zones of the spleen seem to be altered in Tec/
Btknull mice, it remains possible that the failure to respond
properly to TD antigens is a consequence of the altered
splenic microenvironment rather than to an intrinsic B cell
defect.
The reason for the alterations of the splenic B cell areas
and marginal zones is not known. Further experiments will
be required to determine whether the change in the splenic
architecture is caused by the defect in the B cell lineage
and/or by additional defects in other lineages (e.g., metal-
lophilic marginal zone macrophages).
The phenotype of the Tec/Btknull mice resembles par-
tially the phenotype of mice expressing the E41K gain of
function mutant of Btk (51). Both types of mice showed a1621 Ellmeier et al.
similar reduction of peripheral follicular B cell numbers
with a similar immature IgM/IgD profile, no TI-II, and al-
most absent TD immune responses, and altered B cell areas
and marginal zones in the spleen. However, proliferation
in response to anti-IgM stimulation was observed in trans-
genic E41K Btk mice, even on a Btknull background. Thus
it remains to be determined whether the similarity in the
phenotypes is caused by the same mechanisms. It has been
suggested that E41K Btk mimics BCR engagement and
therefore transgenic B cells may resemble autoreactive B
cells that are eliminated (51). The absence of mature B
cells in Tec/Btknull mice is more likely explained by a re-
duction in the life span and/or a block in the maturation of
immature splenic B cells as a consequence of lack of BCR
signaling.
Differential Requirement for Tec and Btk in Humans versus
Mice: How Is Specificity Regulated among Tec Kinases? A
question only indirectly addressed in this study is why mu-
tations in Btk result in a more severe phenotype in humans
than in mice. Our results clearly demonstrate that Tec func-
tionally compensates for loss of Btk in Btknull mice during B
cell development, thus providing an explanation for why B
cell development is little affected in Btk-deficient mice.
However, inactivation of human Btk causes a severe block
during B cell development. It remains to be determined
whether Tec is expressed in primary human pro- or pre-B
cells, although it has been shown that Tec is expressed in
human pro-B, pre-B, and mature B lymphoid cell lines,
and even in EBV-transformed B lymphoblastoid cell lines
derived from XLA patients (27). This raises the important
question of how specificity is regulated among Tec kinases.
In murine B cells, Btk is able to fully compensate for loss of
Tec, but Tec is not able to fully compensate for loss of Btk.
Similar observations have also been made in T cells for the
Tec kinase family members Rlk and Itk: loss of Rlk, unlike
Itk, does not affect T cell function, although combined de-
letion of both kinases results in a stronger phenotype (24).
Whether specificity is determined by specific substrates or
interacting proteins, or by different affinities to the same
binding partners remains to be studied. Another possibility
is that the expression levels of the different kinases deter-
mine whether one kinase is able to compensate for another.
It has been shown that the ability of a transgene to fully res-
cue the xid defect depends on its expression levels. Low
level expression of Btk was sufficient to generate normal
numbers of peripheral B cells, but rescue of signaling de-
fects of xid B cells was inefficient (52). Dosage dependency
has also been observed during the analysis of Tec/Btk dou-
ble-deficient mice. On a Btk-deficient background, Tec1/2
mice had an intermediate B to T cell ratio phenotype com-
pared with Tec1/1 and Tec2/2 mice (Ellmeier, W., and
D.R. Littman, unpublished data), again suggesting that dos-
age of Tec kinases influences B cell numbers.
In summary, the generation of Tec kinase–deficient
mice revealed that the absence of Tec kinase causes no ma-
jor phenotypic alteration of the immune system. By gener-
ating Tec/Btk double-deficient mice, we could show that
Btk compensates for the loss of Tec in the B cell lineage
and that the activity of either Tec or Btk is required for the
proper generation of immature B cells. However, as Btk-
deficient mice, but not Tecnull mice, show a moderate re-
duction of pre-B cells, Btk function appears to be more im-
portant than that of Tec during B cell development. In the
periphery, Btk appears to have additional unique functions
that are only partially shared by Tec. The availability of
mice deficient for the various members of the Tec kinase
family will also facilitate further studies that address the reg-
ulation of specificity among Tec kinases in hematopoietic
cells in more detail.
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